Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Parasitol ; 179(4): 318-23, 2011 Jul 15.
Article in English | MEDLINE | ID: mdl-21777733

ABSTRACT

Four laboratory studies were conducted to demonstrate that a single topical dose of a novel spot-on combination containing fipronil, amitraz and (S)-methoprene (CERTIFECT™, Merial Limited, GA, USA) is efficacious against the brown dog tick, Rhipicephalus sanguineus. In each study, 6-8 male and 6-8 female purpose-bred, laboratory mongrels, terrier cross or Beagles were randomly assigned to one of two study groups (treated and untreated), based on pre-treatment parasite counts. Starting on the day before treatment, each dog was infested weekly with 50 ticks. Ticks were thumb counted at various time points after treatment and weekly infestations starting as early as 6h and continued at 12, 18 and 24h depending on the study. Ticks were removed and counted at 48 h after treatment and weekly infestations. CERTIFECT provided rapid and excellent control of pre-existing and newly acquired infestations of R. sanguineus with efficacy as high as 93% within the first 12h after a single topical treatment. Excellent control (>96%) of R. sanguineus as early as 18 h, following post treatment infestations was maintained for at least 35 days.


Subject(s)
Dog Diseases/drug therapy , Insecticides/therapeutic use , Rhipicephalus sanguineus/drug effects , Tick Infestations/veterinary , Administration, Topical , Animals , Dog Diseases/parasitology , Dog Diseases/prevention & control , Dogs , Drug Combinations , Female , Insecticides/pharmacology , Male , Methoprene/pharmacology , Methoprene/therapeutic use , Pyrazoles/pharmacology , Pyrazoles/therapeutic use , Random Allocation , Rhipicephalus sanguineus/growth & development , Rhipicephalus sanguineus/physiology , South Africa , Tick Control/methods , Tick Infestations/drug therapy , Tick Infestations/parasitology , Tick Infestations/prevention & control , Toluidines/pharmacology , Toluidines/therapeutic use , Treatment Outcome , United States
2.
Vet Parasitol ; 179(4): 330-4, 2011 Jul 15.
Article in English | MEDLINE | ID: mdl-21777735

ABSTRACT

Four studies were conducted to show the effectiveness of a novel combination of fipronil, amitraz and (S)-methoprene in a spot-on formulation (CERTIFECT™, Merial Limited, GA, USA) for the therapeutic and preventive control of Ixodid tick species affecting dogs in Europe: Ixodes ricinus, Dermacentor reticulatus and Rhipicephalus sanguineus. In each, untreated control dogs were compared to others treated with the novel combination. All dogs were infested with 50 adult, unfed ticks prior to treatment and at 7-day intervals after treatment. Ticks on all dogs were counted at 18, 24 and 48 h after treatment (therapeutic efficacy) or infestation (preventive efficacy). Therapeutic efficacy of fipronil, amitraz and (S)-methoprene was excellent as shown by significant (p<0.05) and greater than 97% and up to 100% reductions in the 48 h tick counts and significant (p<0.05) detachment/death of ticks evident at 18-24h after treatment for all three tick species. Preventive efficacy was demonstrated by significant (p<0.05) and greater than 93% and up to 100% reductions in tick counts at 48 h after repeat infestations out to 35 days after treatment for I. ricinus and out to 42 days after treatment for D. reticulatus and R. sanguineus. The time to substantial disruption of establishment of new tick infestations after treatment was less than 18-24h and was maintained for up to 28 days after treatment of I. ricinus and D. reticulatus infestations, and 4h to at most 18 h and maintained up to 35 days after treatment of R. sanguineus. Similar preventive efficacy profiles for each of the Ixodid species tested suggest that CERTIFECT kills all Ixodid species starting 4h after contact as demonstrated for R. sanguineus.


Subject(s)
Dermacentor/drug effects , Dog Diseases/drug therapy , Insecticides/therapeutic use , Ixodes/drug effects , Rhipicephalus sanguineus/drug effects , Tick Infestations/veterinary , Administration, Topical , Animals , Dermacentor/growth & development , Dermacentor/physiology , Dog Diseases/parasitology , Dog Diseases/prevention & control , Dogs , Double-Blind Method , Drug Combinations , Europe , Female , Insecticides/pharmacology , Ixodes/growth & development , Ixodes/physiology , Male , Methoprene/pharmacology , Methoprene/therapeutic use , Pyrazoles/pharmacology , Pyrazoles/therapeutic use , Rhipicephalus sanguineus/growth & development , Rhipicephalus sanguineus/physiology , Tick Control/methods , Tick Infestations/drug therapy , Tick Infestations/parasitology , Tick Infestations/prevention & control , Toluidines/pharmacology , Toluidines/therapeutic use , Treatment Outcome
3.
Vet Parasitol ; 179(4): 343-50, 2011 Jul 15.
Article in English | MEDLINE | ID: mdl-21777737

ABSTRACT

Four groups of seven dogs were treated topically with a novel combination of fipronil, amitraz and (S)-methoprene in a spot-on formulation (CERTIFECT™, Merial Limited, GA, USA) on 28, 21, 14 and 7 days prior to tick infestation, respectively and acaricidal efficacy and transmission blocking compared with an untreated control group (seven dogs). All dogs were infested with adult Dermacentor reticulatus ticks harbouring Babesia canis canis. Babesia canis canis was transmitted by D. reticulatus to all seven untreated control dogs, confirmed following demonstration of clinical signs, by the detection of B. canis parasites in thin blood smears and B. canis canis PCR-RLB DNA assay on blood and the development of B. canis canis antibody titres by 14-21 days after tick infestation. The majority of treated dogs remained sero-negative for 42 days after infestation. Therefore, the treatment of dogs with CERTIFECT applied up to 28 days prior to infestation with D. reticulatus harbouring B. canis canis, successfully prevented the development of clinical signs of canine babesiosis.


Subject(s)
Arachnid Vectors/drug effects , Babesiosis/veterinary , Dermacentor/drug effects , Dog Diseases/drug therapy , Insecticides/therapeutic use , Tick Infestations/veterinary , Administration, Topical , Animals , Arachnid Vectors/parasitology , Arachnid Vectors/physiology , Babesia/physiology , Babesiosis/parasitology , Babesiosis/prevention & control , Babesiosis/transmission , Dermacentor/parasitology , Dermacentor/physiology , Dog Diseases/parasitology , Dog Diseases/prevention & control , Dog Diseases/transmission , Dogs , Double-Blind Method , Drug Combinations , Europe , Female , Insecticides/pharmacology , Male , Methoprene/pharmacology , Methoprene/therapeutic use , Pyrazoles/pharmacology , Pyrazoles/therapeutic use , Tick Control/methods , Tick Infestations/drug therapy , Tick Infestations/parasitology , Tick Infestations/prevention & control , Time Factors , Toluidines/pharmacology , Toluidines/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...